查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1886015

全球幽门螺旋桿菌诊断市场

Helicobacter Pylori Diagnostics
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 158 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2030年，全球幽门螺旋桿菌诊断市场规模将达9.641亿美元。

2024年全球幽门螺旋桿菌诊断市场规模预估为7.28亿美元，预估至2030年将达9.641亿美元，在分析期间（2024-2030年）内复合年增长率（CAGR）为4.8%。本报告分析的细分市场之一－医院终端用户市场，预计复合年增长率为4.8%，到分析期末将达到4.369亿美元。诊断中心终端用户细分市场预计在分析期间内复合年增长率为5.1%。

美国市场规模估计为1.915亿美元，而中国市场预计将以7.2%的复合年增长率成长。

据估计，2024年美国幽门螺旋桿菌诊断市场规模将达1.915亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到2.1亿美元，在2024年至2030年的分析期间内，复合年增长率（CAGR）为7.2%。其他值得关注的区域市场分析包括日本和加拿大，预计在分析期间内，两国的复合年增长率分别为2.6%和4.4%。在欧洲，德国的复合年增长率预计约为2.8%。

全球幽门螺旋桿菌诊断市场—主要趋势与驱动因素摘要

幽门螺旋桿菌感染的诊断对肠道健康重要吗？

幽门螺旋桿菌（H. pylori）的诊断在胃肠道健康管理中日益重要，但为什么诊断这种细菌如此重要？幽门螺旋桿菌广泛存在于胃黏膜中，是多种消化系统疾病的主要原因，包括胃炎、消化性溃疡，在某些情况下甚至会导致胃癌。由于幽门螺旋桿菌能够在胃部的强酸性环境中生存，因此即使不进行治疗，感染也可能持续多年，可能导致慢性消化系统疾病和长期健康问题。早期准确检测对于预防这些疾病的进展至关重要。

诊断幽门螺旋桿菌感染疾病至关重要，因为其症状常与其他胃肠道疾病相似，若不进行特异性检测则难以确诊。由于腹痛、腹胀、噁心和消化不良等症状通用于多种胃肠道疾病，因此准确诊断有助于将幽门螺旋桿菌感染与其他病因区分开来。目前有多种幽门螺旋桿菌检测方法，包括血液检测、粪便检验和呼吸检测等非侵入性检测，以及内视镜检查和切片检查等侵入性检测。虽然每种检测方法的准确性因具体情况而异，但早期发现是预防严重併发症的关键。随着人们对幽门螺旋桿菌与严重胃肠道疾病之间关联的认识不断提高，准确诊断对于有效治疗和管理的重要性也日益凸显。

技术如何改善幽门螺旋桿菌的诊断？

技术进步显着提高了幽门螺旋桿菌诊断的准确性、速度和便利性，为满足各种临床需求提供了更多选择。其中一项最重要的创新是尿素呼吸检测，它已成为目前应用最广泛的非侵入性幽门螺旋桿菌感染检测方法。此试验的原理是测量患者服用尿素溶液后呼出气体中的碳同位素。如果体内存在幽门螺旋桿菌，细菌会分解尿素，释放出二氧化碳，而二氧化碳可以透过呼气检测出来。此方法结果高度准确，尤其适用于治疗前后确认感染情况，使其成为侵入性检测方法的可靠替代方案。

另一项重大进展是粪便抗原检测，它可以检测患者粪便样本中的幽门螺旋桿菌蛋白。现代粪便抗原检测具有高灵敏度和特异性，为诊断活动性性行为感染提供了一种便利、非侵入性的选择。这些检测在内视镜检查或呼吸检测不易进行的地区尤其有用，其价格低廉且易于获取，因此在临床实践中得到了越来越广泛的应用。

内视镜检查和切片检查等侵入性检测方法也显示出诊断准确性的提高。切片检查技术和分子检测技术的进步使得检测幽门螺旋桿菌菌株的抗生素抗药性成为可能，有助于制定更有效的治疗策略。诸如聚合酵素链锁反应（PCR）等分子诊断方法可以检测导致幽门螺旋桿菌对常用抗生素产生抗药性的特定基因，有助于应对因抗药性菌株导致的治疗失败这一日益严峻的挑战。这些技术进步提高了幽门螺旋桿菌的诊断效率，实现了更早期、更精准的检测以及更有针对性的治疗方案。

为什么幽门螺旋桿菌诊断对公共卫生至关重要？

幽门螺旋桿菌的诊断对于公共卫生至关重要，因为这种细菌广泛流行，且与严重的胃肠道疾病密切相关。据估计，全球超过一半的人口感染了幽门螺旋桿菌，但许多人并无症状。然而，一旦出现症状，感染可能导致严重的后果，包括慢性胃炎、消化性溃疡，甚至在极端情况下会发展为胃癌。世界卫生组织（WHO）已将幽门螺旋桿菌列为1类致癌性，因为它与胃癌密切相关，因此早期检测是降低这种致命疾病发生率的首要任务。

定期检测至关重要，尤其是在胃肠道疾病高风险族群中，例如幽门螺旋桿菌感染率高或医疗资源匮乏的地区。早期诊断和治疗幽门螺旋桿菌感染可以预防消化性溃疡的发生，并显着降低胃癌的风险，进而改善长期健康状况。这在资源匮乏的国家尤其重要，因为胃癌仍然是这些国家癌症相关死亡的主要原因之一。

在临床实践中，诊断幽门螺旋桿菌感染对于治疗反覆出现的胃肠道症状至关重要，因为这些症状常常被误诊为其他原因。慢性消化不良、胃炎或溃疡患者通常接受安宁疗护，而未针对潜在的细菌感染进行治疗。如果没有正确的诊断，这些患者可能会持续出现復发症状，或随着时间的推移而出现严重的併发症。准确的检测能够帮助临床医生提供标靶治疗，根除感染并预防復发，从而改善患者预后并降低医疗成本。随着人们对幽门螺旋桿菌在胃病中作用的认识不断提高，诊断技术正成为旨在减轻全球胃肠道疾病负担的公共卫生措施的基石。

哪些因素正在推动幽门螺旋桿菌诊断市场的成长？

幽门螺旋桿菌诊断市场的成长是由多种因素共同推动的，包括公众意识的提高、技术的进步以及对有效管理胃肠道疾病需求的不断增长。其中一个关键驱动因素是人们日益认识到幽门螺旋桿菌感染与胃癌和消化性溃疡等严重健康问题之间的关联。随着越来越多的医疗专业人员和公共卫生组织强调早期检测和治疗的重要性，对可靠且易于使用的诊断工具的需求正在飙升。在幽门螺旋桿菌感染率高的国家，这一点尤其明显，因为筛检和早期治疗可以显着降低胃癌的发生率。

技术进步也是推动市场成长的主要因素。诸如非侵入性尿素呼吸检测和高精度粪便抗原检测等创新技术，使幽门螺旋桿菌的诊断更加便捷，医疗机构无需进行侵入性操作筛检和诊断感染。这些进步也使得患者更容易在门诊或家中接受检测，扩大了诊断服务的覆盖范围，并提高了早期发现的可能性。此外，PCR检测等分子诊断技术的进步使得检测抗药性幽门螺旋桿菌菌株成为可能，有助于应对日益严峻的抗药性挑战，并提高根除治疗的成功率。

抗药性幽门螺旋桿菌菌株的增加也推动了对更先进诊断方法的需求。由于抗生素抗药性使治疗复杂化，因此在治疗开始前检测抗药性菌株至关重要。透过识别抗药性模式，这些诊断技术可以帮助医生开立最有效的抗生素，从而降低治疗失败的风险并防止抗药性细菌的传播。随着医疗系统在努力改善治疗效果的同时对抗抗生素抗药性，这种向精准医疗的转变正在推动诊断市场的发展。

最后，人们对预防性医疗保健的日益重视正在推动对幽门螺旋桿菌诊断的需求。许多医疗保健系统已实施针对高风险族群的筛检项目，旨在检测和治疗幽门螺旋桿菌感染，防止其发展为更严重的疾病。这种预防方法不仅能改善患者的治疗效果，还能降低治疗晚期胃病相关的长期医疗成本。随着全球医疗保健趋势继续优先考虑早期检测和精准治疗，对准确且易于获取的幽门螺旋桿菌诊断的需求预计将会增加，并成为医疗诊断市场的关键成长领域。

部分：

检测类型（侵入性、非侵入性）、最终用途（医院、诊断中心、诊所）

受访公司范例

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Cardinal Health, Inc.
  • DiaSorin SpA
  • Exalenz Bioscience Ltd.
  • F. Hoffmann-La Roche AG
  • Halyard Health, Inc.
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具，改变您分析市场和竞争情报的方式。

Market Glass, Inc. 并没有采用查询LLM 或产业专用的SLM 的典型方法，而是建立了一个由世界各地领域专家精心策划的内容库，其中包括影片文字稿、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

在最新发布的报告中，Market Glass, Inc. 将关税对地理市场的影响纳入考量，并根据公司总部所在地、製造地以及进出口（成品和OEM产品）情况，预测企业竞争地位的变化。这种复杂多变的市场现实会从多个方面影响竞争对手，包括增加销货成本、降低盈利和重组供应链，同时也会影响微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 亚太其他地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP12332

Global Helicobacter Pylori Diagnostics Market to Reach US$964.1 Million by 2030

The global market for Helicobacter Pylori Diagnostics estimated at US$728.0 Million in the year 2024, is expected to reach US$964.1 Million by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$436.9 Million by the end of the analysis period. Growth in the Diagnostics Centers End-Use segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$191.5 Million While China is Forecast to Grow at 7.2% CAGR

The Helicobacter Pylori Diagnostics market in the U.S. is estimated at US$191.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$210.0 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Helicobacter Pylori Diagnostics Market - Key Trends and Drivers Summarized

Is Helicobacter Pylori Diagnostics Crucial for Stomach Health?

Helicobacter pylori (H. pylori) diagnostics are becoming increasingly important in the management of gastrointestinal health, but what makes diagnosing this bacteria so critical? H. pylori is a type of bacteria commonly found in the stomach lining and is the leading cause of various gastrointestinal disorders, including gastritis, peptic ulcers, and, in some cases, gastric cancer. Because of its ability to survive in the harsh acidic environment of the stomach, H. pylori infections can persist for years without treatment, leading to chronic digestive issues and long-term health complications. Early and accurate detection is essential to preventing the progression of these conditions.

Diagnosing H. pylori infections is crucial because symptoms can often mimic other gastrointestinal problems, making it difficult to identify without specific tests. Symptoms like abdominal pain, bloating, nausea, and indigestion are common in many digestive disorders, so accurate diagnostics help differentiate H. pylori infections from other causes. Tests for H. pylori range from non-invasive methods, such as blood tests, stool tests, and breath tests, to invasive procedures like endoscopy and biopsy. Each test offers varying degrees of accuracy, depending on the situation, but early detection is key in preventing severe complications. As awareness of H. pylori’s link to serious gastrointestinal diseases grows, the demand for precise diagnostics is becoming more critical to effective treatment and management.

How Has Technology Improved Helicobacter Pylori Diagnostics?

Technological advancements have significantly improved the accuracy, speed, and ease of Helicobacter pylori diagnostics, offering a range of options tailored to different clinical needs. One of the most significant innovations is the urea breath test, which has become one of the most widely used non-invasive methods for detecting H. pylori infections. This test works by measuring carbon isotopes in the breath after a patient ingests a urea solution. If H. pylori is present, the bacteria will break down the urea, releasing carbon dioxide that can be detected in the breath. This method provides highly accurate results and is particularly useful for confirming infection before and after treatment, offering a reliable alternative to more invasive testing.

Another major advancement is in stool antigen testing, which detects H. pylori proteins in a patient's stool sample. Modern stool antigen tests are highly sensitive and specific, offering a convenient, non-invasive option for diagnosing active infections. These tests are particularly valuable in areas where endoscopy or breath tests may not be readily available, and they are increasingly used in clinical settings due to their affordability and accessibility.

Invasive testing methods, such as endoscopy with biopsy, have also seen improvements in diagnostic accuracy. Advances in biopsy techniques and molecular testing now allow for the detection of antibiotic resistance in H. pylori strains, guiding more effective treatment strategies. Molecular diagnostics, such as PCR (polymerase chain reaction), can detect specific genes in H. pylori that confer resistance to commonly used antibiotics, helping to address the rising challenge of treatment failure due to drug-resistant strains. These technological breakthroughs have made H. pylori diagnostics more effective, enabling earlier and more precise detection and better-targeted treatment plans.

Why Are Helicobacter Pylori Diagnostics Essential for Public Health?

H. pylori diagnostics are essential for public health due to the bacteria’s widespread prevalence and its role in severe gastrointestinal diseases. It is estimated that over half of the global population is infected with H. pylori, though many remain asymptomatic. However, for those who do develop symptoms, the consequences can be serious, including chronic gastritis, peptic ulcers, and, in extreme cases, gastric cancer. The World Health Organization (WHO) has classified H. pylori as a Group 1 carcinogen due to its strong link to stomach cancer, making early detection a priority for reducing the incidence of this deadly disease.

Routine testing for H. pylori is particularly important in populations at high risk for gastrointestinal disorders, including regions where H. pylori infection rates are high or where access to healthcare is limited. Diagnosing and treating H. pylori infections early can prevent the development of peptic ulcers and significantly reduce the risk of stomach cancer, improving long-term health outcomes. This is especially important in countries with limited resources, where gastric cancer remains one of the leading causes of cancer-related deaths.

In clinical practice, diagnosing H. pylori is crucial for managing recurrent gastrointestinal symptoms that are often misattributed to other causes. Patients with chronic indigestion, gastritis, or ulcers are often treated symptomatically without addressing the underlying bacterial infection. Without proper diagnostics, these patients may continue to suffer from recurring symptoms or develop more serious complications over time. Accurate testing helps clinicians provide targeted treatments that eradicate the infection and prevent relapses, leading to better patient outcomes and reduced healthcare costs. As awareness of H. pylori's role in gastric diseases grows, diagnostics are becoming a cornerstone of public health initiatives aimed at reducing the global burden of stomach disorders.

What Factors Are Driving the Growth of the Helicobacter Pylori Diagnostics Market?

The growth in the Helicobacter pylori diagnostics market is driven by a combination of rising awareness, technological advancements, and increasing demand for effective management of gastrointestinal disorders. One of the primary drivers is the growing recognition of the link between H. pylori infection and serious health issues such as gastric cancer and peptic ulcers. As more healthcare professionals and public health organizations emphasize the importance of early detection and treatment, the demand for reliable, accessible diagnostic tools has surged. This is particularly true in countries with high H. pylori infection rates, where screening and early treatment can significantly reduce the incidence of gastric cancer.

Technological advancements are another major factor propelling market growth. Innovations such as non-invasive urea breath tests and highly accurate stool antigen tests have made H. pylori diagnostics more accessible and convenient, allowing healthcare providers to screen and diagnose infections without the need for invasive procedures. These advancements have made it easier for patients to be tested in outpatient or even home settings, broadening the reach of diagnostic services and increasing the likelihood of early detection. In addition, the development of molecular diagnostics, such as PCR tests, allows for the detection of antibiotic-resistant H. pylori strains, helping to combat the growing problem of treatment resistance and improve the success rates of eradication therapies.

The increasing prevalence of drug-resistant H. pylori strains is also driving demand for more advanced diagnostics. As antibiotic resistance continues to complicate treatment, the need for tests that can detect resistant strains before treatment is initiated has become critical. By identifying resistance patterns, these diagnostics help physicians prescribe the most effective antibiotics, reducing the likelihood of treatment failure and preventing the spread of resistant bacteria. This shift toward precision medicine is driving growth in the diagnostics market as healthcare systems seek to improve treatment outcomes while combating antibiotic resistance.

Lastly, the growing focus on preventive healthcare is pushing the demand for H. pylori diagnostics. Many health systems are adopting screening programs aimed at high-risk populations to detect and treat H. pylori infections before they lead to more severe diseases. This preventive approach not only improves patient outcomes but also reduces the long-term healthcare costs associated with treating advanced gastric diseases. As global healthcare trends continue to prioritize early detection and precision treatment, the demand for accurate and accessible H. pylori diagnostics is set to rise, making it a critical area of growth in the medical diagnostics market.

SCOPE OF STUDY:

The report analyzes the Helicobacter Pylori Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (Invasive, Non-Invasive); End-Use (Hospitals, Diagnostics Centers, Clinics)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 12 Featured) -

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Cardinal Health, Inc.
  • DiaSorin SpA
  • Exalenz Bioscience Ltd.
  • F. Hoffmann-La Roche AG
  • Halyard Health, Inc.
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Global Economic Update
    • Helicobacter Pylori Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Helicobacter Pylori Infections Drives Demand for Diagnostic Solutions
    • Growth in Gastrointestinal Disease Screening Expands Addressable Market for H. Pylori Diagnostics
    • Increasing Focus on Early Detection and Treatment of Peptic Ulcers Spurs Adoption of H. Pylori Testing
    • Growth in Use of Urea Breath Tests (UBT) for Non-invasive H. Pylori Detection Drives Adoption
    • Increasing Demand for Point-of-care Testing Solutions Expands Market for H. Pylori Diagnostics
    • Expansion of Diagnostic Laboratories and Healthcare Facilities Boosts Availability of H. Pylori Testing
    • Market Dynamics Driven by Rising Prevalence of Antibiotic-resistant Strains of H. Pylori
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Diagnostics Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Diagnostics Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Diagnostics Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Invasive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Non-Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Non-Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Non-Invasive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Helicobacter Pylori Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • JAPAN
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • CHINA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • EUROPE
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • GERMANY
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • INDIA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • AFRICA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030

IV. COMPETITION